Sharman Moser S - Search Results

1

Real-world treatment patterns, biomarker testing, and clinical outcomes of metastatic non-small cell lung cancer patients in the immunotherapy era.

Apter L, Sharman Moser S, Arunachalam A, Gazit S, Hoshen M, Chodick G, Siegelmann-Danieli N. Apter L, et al. Among authors: sharman moser s. Front Oncol. 2024 Oct 25;14:1442909. doi: 10.3389/fonc.2024.1442909. eCollection 2024. Front Oncol. 2024. PMID: 39512773 Free PMC article.

2

Mapping the patient journey and treatment patterns in early-stage (stage I-III) non-small cell lung cancer.

Sharman Moser S, Yaari S, Apter L, Poellinger B, Rheenen M, Arunachalam A, Chodick G, Hoshen M, Gazit S, Siegelmann-Danieli N. Sharman Moser S, et al. Cancer Epidemiol. 2024 Dec;93:102678. doi: 10.1016/j.canep.2024.102678. Epub 2024 Oct 1. Cancer Epidemiol. 2024. PMID: 39357215 Free article.

3

Healthcare resource utilization and associated cost in patients with metastatic non-small cell lung cancer treated in the immunotherapy era.

Apter L, Sharman Moser S, Gazit S, Chodick G, Hoshen M, Greenberg D, Siegelmann-Danieli N. Apter L, et al. Among authors: sharman moser s. Oncologist. 2024 Sep 28:oyae240. doi: 10.1093/oncolo/oyae240. Online ahead of print. Oncologist. 2024. PMID: 39340826 Free article.

4

Clinical Outcomes of Patients with HER2 Positive Metastatic Breast Cancer to the Brain, with First-Line Trastuzumab, Pertuzumab and Chemotherapy, in a Real-World Setting.

Sharman Moser S, Apter L, Livnat I, Ginsburg R, Yarden A, Drori M, Drizon A, Chodick G, Siegelmann-Danieli N. Sharman Moser S, et al. Breast Cancer (Dove Med Press). 2024 Mar 6;16:105-116. doi: 10.2147/BCTT.S439158. eCollection 2024. Breast Cancer (Dove Med Press). 2024. PMID: 38464505 Free PMC article.

5

Reply to "Metformin as a booster or obstacle of immunotherapy in patients with non-small cell lung cancer and diabetes mellitus".

Leshem Y, Dolev Y, Siegelmann-Danieli N, Sharman Moser S, BPharm LA, Chodick G, Nikolaevski-Berlin A, Shamai S, Merimsky O, Wolf I. Leshem Y, et al. Among authors: sharman moser s. Cancer. 2024 Jan;130(2):324. doi: 10.1002/cncr.35134. Epub 2023 Nov 21. Cancer. 2024. PMID: 37987227 Free article. No abstract available.

6

Association between diabetes mellitus and reduced efficacy of pembrolizumab in non-small cell lung cancer.

Leshem Y, Dolev Y, Siegelmann-Danieli N, Sharman Moser S, Apter L, Chodick G, Nikolaevski-Berlin A, Shamai S, Merimsky O, Wolf I. Leshem Y, et al. Among authors: sharman moser s. Cancer. 2023 Sep 15;129(18):2789-2797. doi: 10.1002/cncr.34918. Epub 2023 Jun 24. Cancer. 2023. PMID: 37354065 Free article.

7

The reimbursement process in three national healthcare systems: variation in time to reimbursement of pembrolizumab for metastatic non-small cell lung cancer.

Sharman Moser S, Tanser F, Siegelmann-Danieli N, Apter L, Chodick G, Solomon J. Sharman Moser S, et al. J Pharm Policy Pract. 2023 Feb 16;16(1):22. doi: 10.1186/s40545-023-00529-0. J Pharm Policy Pract. 2023. PMID: 36797806 Free PMC article. Review.

8

Epidemiology of treatment resistant depression among major depressive disorder patients in Israel.

Sharman Moser S, Chodick G, Gelerstein S, Barit Ben David N, Shalev V, Stein-Reisner O. Sharman Moser S, et al. BMC Psychiatry. 2022 Aug 11;22(1):541. doi: 10.1186/s12888-022-04184-8. BMC Psychiatry. 2022. PMID: 35948895 Free PMC article.

9

Cancer-associated venous thromboembolism in Israel: Incidence, risk factors, treatment, and health care utilization in a population based cohort study.

Sharman Moser S, Spectre G, Raanani P, Friedman-Mazursky O, Tirosh M, Chodick G, Leader A. Sharman Moser S, et al. Res Pract Thromb Haemost. 2022 May 23;6(4):e12653. doi: 10.1002/rth2.12653. eCollection 2022 May. Res Pract Thromb Haemost. 2022. PMID: 35619639 Free PMC article.

10

Predictors of treatment initiation and mapping the cancer diagnostic pathway: A retrospective observational cohort study of patients with metastatic non-small cell lung cancer.

Sharman Moser S, Yaari S, Urban D, Apter L, Passwell N, Teper G, Chodick G, Siegelmann-Danieli N. Sharman Moser S, et al. Cancer Epidemiol. 2022 Aug;79:102156. doi: 10.1016/j.canep.2022.102156. Epub 2022 May 17. Cancer Epidemiol. 2022. PMID: 35594797

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters